Breast Cancer Risk Factors among Asian Versus Caucasian Women with BRCA1/2 Mutations.

被引：0
|
作者：
de Bruin, M. A. [1 ]
Goldstein, B. A. [1 ]
Lipson, J. A. [1 ]
Ikeda, D. M. [1 ]
McPherson, L. A. [1 ]
Sharma, B. [1 ]
Kardashian, A. [1 ]
Schackmann, E. A. [1 ]
Kingham, K. E. [1 ]
Mills, M. A. [1 ]
West, D. W. [1 ]
Ford, J. M. [1 ]
Kurian, A. W. [1 ]
机构：
[1] Stanford Univ, Sch Med, Stanford, CA 94305 USA
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/0008-5472.SABCS11-P4-10-10
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P4-10-10
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Endocrine interventions in women with BRCA1/2 mutations. A systematic review
    Schueler-Toprak, Susanne
    Seitz, Stephan
    Ortmann, Olaf
    GYNAKOLOGE, 2016, 49 (05): : 348 - 356
  • [22] Immunophenotypic characterization of breast cancers in carriers of BRCA1/BRCA2 mutations.
    Simon, SD
    Bacchi, CE
    Molina, AL
    Moreira-Filho, CA
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 870S - 870S
  • [23] Breast and ovarian cancer screening in women undergoing genetic counseling and genetics testing for BRCA1 and BRCA2 gene mutations.
    Kelly, KM
    Ellington, LA
    Leventhal, H
    Porter, K
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (11) : 2762S - 2762S
  • [24] Oophorectomy for breast cancer prevention in women with BRCA1 or BRCA2 mutations
    Metcalfe, Kelly A.
    WOMENS HEALTH, 2009, 5 (01) : 63 - 68
  • [25] Recurrent BRCA1 and BRCA2 Mutations in Mexican Women with Breast Cancer
    Torres-Mejia, Gabriela
    Royer, Robert
    Llacuachaqui, Marcia
    Akbari, Mohammad R.
    Giuliano, Anna R.
    Martinez-Matsushita, Louis
    Angeles-Llerenas, Angelica
    Ortega-Olvera, Carolina
    Ziv, Elad
    Lazcano-Ponce, Eduardo
    Phelan, Catherine M.
    Narod, Steven A.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2015, 24 (03) : 498 - 505
  • [26] BRCA1/BRCA2 mutations and breast cancer in Ashkenazi Jewish women
    Gilbert, F
    Dabney, MK
    Diemer, K
    Ludwig, S
    Rosenthal, G
    Osborne, MP
    CANCER: GENETICS AND THE ENVIRONMENT, 1997, 833 : 198 - 203
  • [27] BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer
    Couch, FJ
    DeShano, ML
    Blackwood, MA
    Calzone, K
    Stopfer, J
    Campeau, L
    Ganguly, A
    Rebbeck, T
    Weber, BL
    Jablon, L
    Cobleigh, MA
    Hoskins, K
    Garber, JE
    NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (20): : 1409 - 1415
  • [28] Risk factors for detecting germline BRCA1 and BRCA2 founder mutations in Ashkenazi Jewish women with breast or ovarian cancer
    Hodgson, SV
    Heap, E
    Cameron, J
    Ellis, D
    Mathew, CG
    Eeles, RA
    Solomon, E
    Lewis, CM
    JOURNAL OF MEDICAL GENETICS, 1999, 36 (05) : 369 - 373
  • [29] Tamoxifen and risk of contralateral breast cancer among women with inherited mutations in BRCA1 and BRCA2: a meta-analysis
    Xu, Lingyun
    Zhao, Yansheng
    Chen, Zhiqiang
    Wang, Yujiao
    Chen, Lin
    Wang, Shui
    BREAST CANCER, 2015, 22 (04) : 327 - 334
  • [30] Tamoxifen and risk of contralateral breast cancer among women with inherited mutations in BRCA1 and BRCA2: a meta-analysis
    Lingyun Xu
    Yansheng Zhao
    Zhiqiang Chen
    Yujiao Wang
    Lin Chen
    Shui Wang
    Breast Cancer, 2015, 22 : 327 - 334
12345